×
About 465 results

ALLMedicine™ Neuroectodermal Tumors Center

Research & Reviews  171 results

Peripheral primitive neuroectodermal tumor: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969283
Journal of Medical Case Reports; Keka-Sylaj A, Ramosaj A et. al.

Apr 1st, 2022 - Primitive neuroectodermal tumors are extremely rare and highly aggressive malignant small round cell tumors that arise from the primitive nerve cells of the nervous system or outside it. These tumors share similar histology, immunohistologic chara...

A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal Tumors and Compr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870546
Current Oncology (Toronto, Ont.); Kandler T, Cortez E et. al.

Feb 25th, 2022 - Malignant gastrointestinal neuroectodermal tumor (GNET) is an ultra-rare soft tissue sarcoma, therefore often misdiagnosed and has no available standard treatment. Here, we report 3 cases of metastatic GNET with variable clinical courses. Our smal...

Primary Ewing sarcoma/peripheral primitive neuroectodermal tumors in the cranial bone a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742462
BMC Surgery; Chen J, Wu SZ et. al.

Jan 9th, 2022 - Primary Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumors (pPNETs) are aggressive bone tumors that rarely occur in the axial skeleton, including the cranial bone and mobile spine. The purpose of this study was to investigate whether t...

Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671201
The American Journal of Surgical Pathology; Hwang MJ, Hamza A et. al.

Aug 3rd, 2021 - The development of somatic-type malignancies (SMs) in testicular germ cell tumors (GCTs) is a rare but well-recognized phenomenon. We studied the pathologic features of 63 GCTs with SMs in the testis (n=22) or metastases (n=41) and correlated thes...

Neurogenic Tumors of the Mediastinum
https://emedicine.medscape.com/article/427584-print

Aug 2nd, 2021 - Practice Essentials Several tumors of neurogenic origin can occur in the mediastinum. Tumors that occur in this area of the chest can present in many different ways clinically and can produce many different pathologic processes. An understanding o...

see more →

Clinicaltrials.gov  7 results

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
https://clinicaltrials.gov/ct2/show/NCT01217437

Jul 23rd, 2021 - PRIMARY OBJECTIVES: l. To compare the overall survival (OS) of subjects receiving the combination of temozolomide and irinotecan with that of subjects receiving temozolomide, irinotecan (irinotecan hydrochloride), and bevacizumab for recurrent med...

Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
https://clinicaltrials.gov/ct2/show/NCT04300179

Dec 17th, 2020 - Ewing sarcoma (ES) and peripheral primitive neuroectodermal tumor (PNET), Both entities that currently comprise the same spectrum of neoplastic diseases known as the Ewing sarcoma family of tumors (EFT), were originally described as distinct clini...

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
https://clinicaltrials.gov/ct2/show/NCT00001686

Sep 10th, 2020 - Background: Children and adults are referred to the Pediatric Oncology Branch (POB) for possible enrollment in clinical protocols for the treatment of cancer or other rare diseases. While some children are not eligible for a specific protocol, the...

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
https://clinicaltrials.gov/ct2/show/NCT00003273

Dec 3rd, 2015 - OBJECTIVES: Investigate the toxicity of and response rate to an intensification of an induction chemotherapy regimen (regimen A: cisplatin, vincristine, cyclophosphamide, and etoposide) by incorporation of high-dose methotrexate with leucovorin ca...

A Study of of MORAb-004 in Subjects With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT00847054

Jul 16th, 2014 - MORAb-004 is a monoclonal antibody directed against endosialin, a cell surface glycoprotein, which is expressed on cells involved in tumor vasculature. Studies have found endosialin to play a key role in tumor growth and neovessel formation in num...

see more →

News  7 results

Blood-Brain-Barrier Therapy for CNS Tumors May Have Lasting Effect on Vision
https://www.medscape.com/viewarticle/942415

Dec 16th, 2020 - NEW YORK (Reuters Health) - Osmotic blood-brain-barrier disruption (BBBD) therapy, which increases the penetration of chemotherapeutics into malignant tumors of the central nervous system (CNS), may also affect sight, researchers say. "Osmotic blo...

Primitive Neuroectodermal Tumor of the Pancreas in Adults; A Rare and Aggressive Malignancy
https://www.mdedge.com/fedprac/article/227899/oncology/primitive-neuroectodermal-tumor-pancreas-adults-rare-and-aggressive
Prashanth Ashok Kumar, Ali Wazir et. al.

Sep 2nd, 2020 - INTRODUCTION: Primitive neuroectodermal tumors (PNET) are highly aggressive malignancies composed of small round cells that are neuroectodermal in origin similar to Ewings Sarcoma. PNET of the pancreas is extremely rare with around 20 cases report.

CLTX-CAR T cells exhibit preclinical activity and move on to a clinical trial
https://www.mdedge.com/hematology-oncology/article/218418/cns/brain-cancer/cltx-car-t-cells-exhibit-preclinical-activity?channel=39313
Caleb Rans

Mar 4th, 2020 - Chlorotoxin (CLTX)-directed chimeric antigen receptor (CAR) T cells demonstrated activity against glioblastoma in a preclinical study and will soon be tested in a clinical trial. “We sought to develop a CAR T cell using chlorotoxin peptide as the.

CLTX-CAR T cells exhibit preclinical activity and move on to a clinical trial
https://www.mdedge.com/hematology-oncology/article/218418/cns/brain-cancer/cltx-car-t-cells-exhibit-preclinical-activity
Caleb Rans

Mar 4th, 2020 - Chlorotoxin (CLTX)-directed chimeric antigen receptor (CAR) T cells demonstrated activity against glioblastoma in a preclinical study and will soon be tested in a clinical trial. “We sought to develop a CAR T cell using chlorotoxin peptide as the.

Folic Acid Fortification Linked to Drop in Childhood Cancers
https://www.medscape.com/viewarticle/764215

May 21st, 2012 - May 21, 2012 — The US Food and Drug Administration has mandated folic acid supplementation of enriched grain products since 1996. Now, investigators find the rates of some childhood cancers have decreased significantly after that timepoint compare...

see more →

Patient Education  1 results see all →